Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for symptomatic stable asthma
ACTRN12609000197235Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Azithromycin with Placebo (2 arms). Primary endpoints: Asthma exacerbations in non-eosinophilic asthma and Health status. Started Jun 2009; status: completed.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12609000197235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000197235.